<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03424772</url>
  </required_header>
  <id_info>
    <org_study_id>XH-18-001</org_study_id>
    <nct_id>NCT03424772</nct_id>
  </id_info>
  <brief_title>Whole Genome Sequencing in the Detection of Rare Undiagnosed Genetic Diseases in Children in China</brief_title>
  <official_title>Clinical Collaborative Research of Whole Genome Sequencing in the Detection of Rare Undiagnosed Genetic Diseases in Children in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the indications and diagnostic efficiency of whole genome sequencing (WGS) in
      pediatric patients with unexplained intellectual disability/developmental delay, multiple
      congenital abnormalities and other rare and undiagnosed diseases
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This project will recruit 100 rare, undiagnosed pediatric genetic disease families (core
      families: patients, patients' parents, immediate family members such as brothers and sisters,
      all of them can be enrolled whether they have disease or not, so generally 3, for a few cases
      4 or 5) all over the country. The expert team will review the clinical materials, the
      molecular team will review the experimental process, and the bioinformatics team will review
      the chip, the analysis of whole exome sequencing data and screen the samples all over the
      country;

      Whole-genome sequencing of 100 rare, undiagnosed pediatric genetic disease families (Illumina
      NovaSeq High-throughput Sequencer);

      The study will provide preliminarily performance data on the comparison of whole exome data
      and whole genome data. In addition, it will generate the Chinese Consensus on Clinical
      Applications of Whole-genome sequencing in the Diagnosis of Birth Defects and Undiagnosed
      Rare Genetic Diseases in Children based on the statistical analysis of clinical phenotype and
      genotype association, which could guide the clinical application of pediatrics, laboratory
      testing and reporting.

      Construction of the Chinese detection genome database of genetic disease
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 18, 2018</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Family-Based</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Number of diagnosed families</measure>
    <time_frame>1 year</time_frame>
    <description>Families with rare and undiagnosed pediatric genetic disease will be benefitted by WGS.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numbers of pathogenic variants in different variation types</measure>
    <time_frame>1 year</time_frame>
    <description>WGS would have the potential to detect different types of genetic alterations, such as structure variations, point mutation, small insertion/deletion, trinucleotide repeat, etc. Some types could not be identified by exome sequencing and chromosomal microarray. The numbers of the pathogenic variants in these types will be calculated to examine the benefit of WGS.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Intellectual Disability</condition>
  <condition>Multiple Congenital Anomaly</condition>
  <condition>Rare Diseases</condition>
  <arm_group>
    <arm_group_label>Patients with unexplained DD/ID</arm_group_label>
    <description>Whole genome sequencing will be performed on pediatric patients with unexplained developmental delay(DD)/intellectual disability(ID), multiple congenital abnormalities and other rare and undiagnosed diseases.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Whole genome sequencing</intervention_name>
    <description>WGS will be performed for the trio</description>
    <arm_group_label>Patients with unexplained DD/ID</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Genomic DNA will be extracted from whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Undiagnosed Children with intellectual disability/developmental delay and/or multiple
        congenital abnormalites in China
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Intelligence tests results of less than 40 (patients &lt;3 years old using the Gesell
             Developmental Scale for screening; patients of 3-6 years old using Little Wechsler
             Intelligence Scale for screening; patients &gt;6 years old using Old Wechsler
             Intelligence Scale for screening).

          2. Neurodevelopmental defects can be expressed as mental retardation, motor development
             retardation, language delay, epilepsy, etc. May have or not have Multiple congenital
             abnormalities, families with more than one affected patient will be enrolled priority

          3. Families went through at least one of the high throughput technology(WES or CMA) and
             receive the negative result

        Exclusion Criteria:

          1. Intellectual disability caused by pregnancy, perinatal infection, ischemia, and
             hypoxia and other non-hereditary causes,

          2. Obvious genetic metabolic diseases (such as different types of genetic metabolic
             diseases, bone disease, fragile X syndrome, etc.);
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yongguo Yu, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Specify Unaffiliated</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yu Sun, PhD</last_name>
    <phone>+86-25-25076466</phone>
    <email>sunyu@xinhuamed.com.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiaomei Luo, Ms</last_name>
    <phone>+86-25-25076466</phone>
    <email>luoxiaomei@xinhuamed.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking Union Medical College Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhengqing Qiu, PhD</last_name>
      <email>zhengqingqiu33@aliyun.com</email>
    </contact>
    <investigator>
      <last_name>Zhengqing Qiu, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital, Capital Institute of Pediatrics</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoli Chen, PhD</last_name>
      <email>cxlwx@sina.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoli Chen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Pediatrics, Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuwu Jiang, PhD</last_name>
      <email>jiangyw@263.net</email>
    </contact>
    <investigator>
      <last_name>Yuwu Jiang, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Maternal &amp; Child Health Hospital, The Children's Hospital, The Obstetrics &amp; Gynecology Hospital of Guangxi Zhuang Autonomous Region</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530005</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yiping Shen, PhD</last_name>
      <email>yiping.shen@childrens.harvard.edu</email>
    </contact>
    <investigator>
      <last_name>Yiping Shen, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Maternal and Child Health Hospital of Hunan Province</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hua Wang, PhD</last_name>
      <email>wanghua213@aliyun.com</email>
    </contact>
    <investigator>
      <last_name>Hua Wang, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital, Central-south University / Hunan Jiahui genetics hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lingqian Wu, PhD</last_name>
      <phone>0731-84805252</phone>
      <email>wulingqian@sklmg.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Lingqian Wu, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hunan Children's Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jing Peng, PhD</last_name>
      <email>pengjing4346@163.com</email>
    </contact>
    <investigator>
      <last_name>Jing Peng, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nanjing maternal and children hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhengfeng Xu, PhD</last_name>
      <email>njxzf@126.com</email>
    </contact>
    <investigator>
      <last_name>Zhengfeng Xu, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ruijin Hospital affiliated to Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200025</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Wang, PhD</last_name>
      <email>jwangwei88@126.com</email>
    </contact>
    <investigator>
      <last_name>Wei Wang, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Shanghai</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200041</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pin Li, PhD</last_name>
      <email>lipin21@126.com</email>
    </contact>
    <investigator>
      <last_name>Pin Li, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Institute for Pediatric Research</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaomei Luo, MD, PhD</last_name>
      <phone>+86-21-25076466</phone>
      <email>yuyongguo@shsmu.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Yongguo Yu, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xin Hua Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200092</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuefan Gu, MD, PhD</last_name>
      <email>guxuefan@xinhuamed.com.cn</email>
    </contact>
    <investigator>
      <last_name>Xuefan Gu</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Children's Medical Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>201712</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Li, PhD</last_name>
      <email>lifei5861_cn@163.com</email>
    </contact>
    <investigator>
      <last_name>Fei Li, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wenzhou Central Hospital</name>
      <address>
        <city>Wenzhou</city>
        <state>Zhejiang</state>
        <zip>325099</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaohua Tang, PhD</last_name>
      <email>tsh006@163.com</email>
    </contact>
    <investigator>
      <last_name>Shaohua Tang, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pubmed/27915479</url>
    <description>Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing.</description>
  </link>
  <reference>
    <citation>Park ST, Kim J. Trends in Next-Generation Sequencing and a New Era for Whole Genome Sequencing. Int Neurourol J. 2016 Nov;20(Suppl 2):S76-83. Epub 2016 Nov 22. Review.</citation>
    <PMID>27915479</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2018</study_first_submitted>
  <study_first_submitted_qc>February 5, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2018</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</investigator_affiliation>
    <investigator_full_name>Yongguo Yu</investigator_full_name>
    <investigator_title>Associate chief physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rare Diseases</mesh_term>
    <mesh_term>Genetic Diseases, Inborn</mesh_term>
    <mesh_term>Intellectual Disability</mesh_term>
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Abnormalities, Multiple</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>We have not yet decided which part of individual participant data(IPD) can be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

